Article info

Download PDFPDF
Detection of anti-ADAM 10 antibody in serum of a patient with pulmonary fibrosis associated with dermatomyositis

Authors

  • Jiro Fujita aFirst Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan, bSecond Department of Pathology, Kochi Medical School, Kochi, Japan PubMed articlesGoogle scholar articles
  • Tamotsu Takeuchi aFirst Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan, bSecond Department of Pathology, Kochi Medical School, Kochi, Japan PubMed articlesGoogle scholar articles
  • Naomi Dobashi aFirst Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan, bSecond Department of Pathology, Kochi Medical School, Kochi, Japan PubMed articlesGoogle scholar articles
  • Yuji Ohtsuki aFirst Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan, bSecond Department of Pathology, Kochi Medical School, Kochi, Japan PubMed articlesGoogle scholar articles
  • Michiaki Tokuda aFirst Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan, bSecond Department of Pathology, Kochi Medical School, Kochi, Japan PubMed articlesGoogle scholar articles
  • Jiro Takahara aFirst Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan, bSecond Department of Pathology, Kochi Medical School, Kochi, Japan PubMed articlesGoogle scholar articles
  1. Dr J Fujita, First Department of Internal Medicine, Kagawa Medical University, 1750–1, Miki-cho, Kita-gun, Kagawa, 761–0793, Japan.
View Full Text

Citation

Fujita J, Takeuchi T, Dobashi N, et al
Detection of anti-ADAM 10 antibody in serum of a patient with pulmonary fibrosis associated with dermatomyositis

Publication history

  • Accepted July 21, 1999
  • First published December 1, 1999.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.